Idarubicin FDA Link Generic

An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.

Also Known As:

4 Demethoxydaunorubicin; 4-Desmethoxydaunorubicin; IMI-30; Idarubicin Hydrochloride; NSC-256439; 4 Desmethoxydaunorubicin; Hydrochloride, Idarubicin; IMI 30; IMI30; NSC 256439; NSC256439; 4-Demethoxydaunorubicin; 5,12-Naphthacenedione, 9- acetyl- 7- ((3- amino- 2,3,6- trideoxy- alpha- L- lyxo- hexopyranosyl)oxy)- 7,8,9,10- tetrahydro- 6,9,11- trihydroxy- , (7S-cis)-

Pharmalogical Action Categories:

Antibiotics, Antineoplastic
Topoisomerase II Inhibitors

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Idarubicin: 927
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Idarubicin: 927
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Idarubicin: 927

E J Benner Selected Research

E J Benner Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure